1. Home
  2. ADPT vs BTU Comparison

ADPT vs BTU Comparison

Compare ADPT & BTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • BTU
  • Stock Information
  • Founded
  • ADPT 2009
  • BTU 2016
  • Country
  • ADPT United States
  • BTU United States
  • Employees
  • ADPT N/A
  • BTU N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • BTU Coal Mining
  • Sector
  • ADPT Health Care
  • BTU Energy
  • Exchange
  • ADPT Nasdaq
  • BTU Nasdaq
  • Market Cap
  • ADPT 2.0B
  • BTU 1.9B
  • IPO Year
  • ADPT 2019
  • BTU N/A
  • Fundamental
  • Price
  • ADPT $15.53
  • BTU $33.36
  • Analyst Decision
  • ADPT Strong Buy
  • BTU Strong Buy
  • Analyst Count
  • ADPT 10
  • BTU 6
  • Target Price
  • ADPT $13.60
  • BTU $25.50
  • AVG Volume (30 Days)
  • ADPT 2.0M
  • BTU 6.7M
  • Earning Date
  • ADPT 11-06-2025
  • BTU 10-30-2025
  • Dividend Yield
  • ADPT N/A
  • BTU 0.90%
  • EPS Growth
  • ADPT N/A
  • BTU N/A
  • EPS
  • ADPT N/A
  • BTU 1.10
  • Revenue
  • ADPT $205,216,000.00
  • BTU $4,038,200,000.00
  • Revenue This Year
  • ADPT $32.63
  • BTU N/A
  • Revenue Next Year
  • ADPT $16.31
  • BTU $16.00
  • P/E Ratio
  • ADPT N/A
  • BTU $30.27
  • Revenue Growth
  • ADPT 21.60
  • BTU N/A
  • 52 Week Low
  • ADPT $4.27
  • BTU $9.61
  • 52 Week High
  • ADPT $15.94
  • BTU $33.61
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 66.13
  • BTU 77.95
  • Support Level
  • ADPT $14.11
  • BTU $30.82
  • Resistance Level
  • ADPT $15.26
  • BTU $33.29
  • Average True Range (ATR)
  • ADPT 0.73
  • BTU 1.82
  • MACD
  • ADPT 0.12
  • BTU 0.35
  • Stochastic Oscillator
  • ADPT 87.90
  • BTU 97.46

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About BTU Peabody Energy Corporation

Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan and other regions.

Share on Social Networks: